ADRO/(ADXS)—I don't think it's a serious matter. According to today's CC, ADRO's patient did not have a systemic listeria infection, but rather one that was confined to the port.
ADXS addressed a related problem one year ago (#msg-117519581), and it hasn't caused significant damage to the company's clinical programs.
p.s. MarketWatch had a story this morning that apparently conflated ADRO and ADXS, leading investors who read only the headline to wonder whether ADXS had a new clinical hold. (It doesn't.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.